, /PRNewswire/ -- The proteomics market refers to the study of proteomes, encompassing the entire set of proteins produced or modified by an organism or system. It plays a crucial role in understanding biological processes, disease mechanisms, and drug development. According to Technavio, the global proteomics market is expected to grow by .
99 billion from 2024 to 2028, at a CAGR of almost 16.83%. This growth is driven by advancements in proteomics research, particularly in monitoring post-translational modifications (PTMs).
However, the market faces challenges due to a shortage of trained laboratory professionals. Key players include Agilent Technologies Inc., Thermo Fisher Scientific Inc.
, and Bio-Rad Laboratories Inc., among others. Get a detailed analysis on regions, market segments, customer landscape, and companies - The proteomics market has witnessed notable expansion in recent years, fueled by the escalating demand for sophisticated diagnostic tools and personalized medicine.
A prominent trend in proteomics is the heightened attention towards monitoring post-translational modifications (PTMs) of proteins. PTMs are chemical alterations that take place after a protein is translated from its genetic code. These modifications can significantly impact a protein's function, activity, and localization, playing a vital role in regulating biological processes.
Understanding PTMs offers invaluable insights into disease mechanisms and aids in creating targeted therapies. Mass s.
